论文部分内容阅读
肺癌耐药是临床所面临的棘手难题,主要有原发性耐药和临床上较为常见的多次化疗后所出现的获得性耐药[1]。近年来有文献报告通过核素显像对肺部疾病的诊断及疗效判断有一定帮助[2]。我们通过测定99ｍＴｃＭＩＢＩ早期和晚期肿瘤放射性摄取比值的变化,观察肺癌细胞Ｐ170糖蛋白相
Resistant to lung cancer is a difficult problem faced by the clinical, there are primary resistance and clinically more common acquired multiple resistance after the emergence of acquired resistance [1]. In recent years, there are literature reports of radionuclide imaging of lung disease diagnosis and treatment to determine the effectiveness of some help [2]. We measured the 99mTcMIBI early and late tumor radioactive uptake ratio changes observed lung cancer cell P170 glycoprotein phase